Article: | MedLuna.com

Overview

Journal Can Urol Assoc J

Specialty Urology

Date 2009 Jun 23

PMID 19543472

Citations 2

Authors

Joseph L Chin

Affiliations

Soon will be listed here.

Citing Articles

The need for, and utilization of prostate-bed radiotherapy after radical prostatectomy for patients with prostate cancer in British Columbia.

Tyldesley S, Peacock M, Morris J, So A, Kim-Sing C, Quirt J Can Urol Assoc J. 2012; 6(2):89-94.

PMID: 22511413 PMC: 3328560. DOI: 10.5489/cuaj.11158.

Can Urol Assoc J. 2009; 3(3):252.

PMID: 19543475 PMC: 2692159.

References

Pacholke H, Wajsman Z, Algood C, Neulander E, Morris C, Zlotecki R . Postoperative adjuvant and salvage radiotherapy for prostate cancer: impact on freedom from biochemical relapse and survival. Urology. 2004; 64(5):982-6. DOI: 10.1016/j.urology.2004.06.020. View

Morgan S, Waldron T, Eapen L, Mayhew L, Winquist E, Lukka H . Adjuvant radiotherapy following radical prostatectomy for pathologic T3 or margin-positive prostate cancer: a systematic review and meta-analysis. Radiother Oncol. 2008; 88(1):1-9. DOI: 10.1016/j.radonc.2008.04.013. View

Pucar D, Sella T, Schoder H . The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery. Curr Opin Urol. 2007; 18(1):87-97. DOI: 10.1097/MOU.0b013e3282f13ac3. View

Brooks J, Albert P, Wilder R, Gant D, McLeod D, Poggi M . Long-term salvage radiotherapy outcome after radical prostatectomy and relapse predictors. J Urol. 2005; 174(6):2204-8, discussion 2208. DOI: 10.1097/01.ju.0000181223.99576.ff. View

Wadasaki K, Kaneyasu Y, Kenjo M, Matsuura K, Murakami Y, Hashimoto Y . Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer. Int J Clin Oncol. 2007; 12(1):37-41. DOI: 10.1007/s10147-006-0622-1. View

Lennernas B, Edgren M, Haggman M, Norlen B, Nilsson S . Postoperative radiotherapy after prostatectomy--a review. Scand J Urol Nephrol. 2003; 37(1):10-5. DOI: 10.1080/00365590310008613. View

Swanson G, Goldman B, Tangen C, Chin J, Messing E, Canby-Hagino E . The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794. J Urol. 2008; 180(6):2453-7. PMC: 3512115. DOI: 10.1016/j.juro.2008.08.037. View

Chen A, Granchi P, Garcia J, Bucci M, Fu K, Eisele D . Local-regional recurrence after surgery without postoperative irradiation for carcinomas of the major salivary glands: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys. 2007; 67(4):982-7. DOI: 10.1016/j.ijrobp.2006.10.043. View

Van Cangh P, Richard F, Lorge F, Castille Y, Moxhon A, Opsomer R . Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study. J Urol. 1997; 159(1):164-6. DOI: 10.1016/s0022-5347(01)64044-8. View

10.

Teh B, Bastasch M, Mai W, Kattan M, Butler E, Kadmon D . Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical margins. J Urol. 2006; 175(6):2097-101. DOI: 10.1016/S0022-5347(06)00306-5. View

11.

Bolla M, van Poppel H, Collette L, van Cangh P, Vekemans K, Da Pozzo L . Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet. 2005; 366(9485):572-8. DOI: 10.1016/S0140-6736(05)67101-2. View

12.

Amos E, Mendenhall W, McCarty P, Gage J, Emlet J, Lowrey G . Postoperative radiotherapy for locally advanced colon cancer. Ann Surg Oncol. 1996; 3(5):431-6. DOI: 10.1007/BF02305760. View

13.

Thompson I, Tangen C, Paradelo J, Lucia M, Miller G, Troyer D . Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol. 2009; 181(3):956-62. PMC: 3510761. DOI: 10.1016/j.juro.2008.11.032. View

14.

Thompson Jr I, Tangen C, Paradelo J, Lucia M, Miller G, Troyer D . Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA. 2006; 296(19):2329-35. DOI: 10.1001/jama.296.19.2329. View

15.

Stephenson A, Scardino P, Kattan M, Pisansky T, Slawin K, Klein E . Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol. 2007; 25(15):2035-41. PMC: 2670394. DOI: 10.1200/JCO.2006.08.9607. View

16.

Vees H, Buchegger F, Albrecht S, Khan H, Husarik D, Zaidi H . 18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy. BJU Int. 2007; 99(6):1415-20. DOI: 10.1111/j.1464-410X.2007.06772.x. View

17.

Feng M, Hanlon A, Pisansky T, Kuban D, Catton C, Michalski J . Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. Int J Radiat Oncol Biol Phys. 2007; 68(5):1417-23. DOI: 10.1016/j.ijrobp.2007.01.049. View

18.

Chin J . Post-radical prostatectomy management options for the positive surgical margin: argument for adjuvant radiotherapy. Urol Oncol. 2008; 27(1):87-8. DOI: 10.1016/j.urolonc.2008.04.005. View

19.

Bottke D, Wiegel T . [pT3R1 prostate cancer : Immediate or delayed radiotherapy after radical prostatectomy?]. Urologe A. 2008; 47(11):1431-5. DOI: 10.1007/s00120-008-1724-3. View

20.

Caraffini B, De Stefani A, Vitali E, Magri E, Tonoli S, Frata P . Postoperative radiotherapy after radical prostatectomy for prostate carcinoma: the experience of the Brescia Radium Institute. Radiol Med. 2006; 111(5):741-7. DOI: 10.1007/s11547-006-0059-7. View